Cargando…

Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes

Phospholamban (PLN) is a key regulator that controls the function of the sarcoplasmic reticulum (SR) and is required for the regulation of cardiac contractile function. Although PLN-deficient mice demonstrated improved cardiac function, PLN loss in humans can result in dilated cardiomyopathy (DCM) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Youxu, Li, Xiaowei, Guo, Tianwei, Lu, Wen-Jing, Ma, Shuhong, Chang, Yun, Song, Yuanxiu, Zhang, Siyao, Bai, Rui, Wang, Hongyue, Qi, Man, Jiang, Hongfeng, Zhang, Hongjia, Lan, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023809/ https://www.ncbi.nlm.nih.gov/pubmed/35334215 http://dx.doi.org/10.1016/j.stemcr.2022.02.016

Ejemplares similares

KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation
por: Song, Yuanxiu, et al.
Publicado: (2022)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

3213 Unraveling the role of Phospholamban (PLN) in humans via the characterization of Induced Pluripotent Stem Cell (iPSC) Cardiomyocytes (CM) derived from carriers of a lethal PLN mutation
por: Trivieri, Maria Giovanna, et al.
Publicado: (2019)

Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Badone, Beatrice, et al.
Publicado: (2021)

MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling
por: Li, Xiaowei, et al.
Publicado: (2019)

The pseudoenzyme ADPRHL1 affects cardiac function by regulating the ROCK pathway
por: Tian, Lei, et al.
Publicado: (2023)

TSH inhibits SERCA2a and the PKA/PLN pathway in rat cardiomyocytes
por: Dong, Jiajia, et al.
Publicado: (2016)

Impairment of the ER/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation
por: Cuello, Friederike, et al.
Publicado: (2021)

Microscale grooves regulate maturation development of hPSC‐CMs by the transient receptor potential channels (TRP channels)
por: Liu, Taoyan, et al.
Publicado: (2021)

DNA binding kinetics of two response regulators, PlnC and PlnD, from the bacteriocin regulon of Lactobacillus plantarum C11
por: Straume, Daniel, et al.
Publicado: (2009)

PlnTFDB: an integrative plant transcription factor database
por: Riaño-Pachón, Diego Mauricio, et al.
Publicado: (2007)

RAD-Deficient Human Cardiomyocytes Develop Hypertrophic Cardiomyopathy Phenotypes Due to Calcium Dysregulation
por: Li, Ya’nan, et al.
Publicado: (2020)

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
por: Caudal, Arianne, et al.
Publicado: (2022)

Cell sheet formation enhances the therapeutic effects of human umbilical cord mesenchymal stem cells on myocardial infarction as a bioactive material
por: Guo, Rui, et al.
Publicado: (2021)

A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations
por: Truszkowska, Grażyna T, et al.
Publicado: (2015)

Knockout of MYOM1 in human cardiomyocytes leads to myocardial atrophy via impairing calcium homeostasis
por: Hang, Chengwen, et al.
Publicado: (2021)

Modelling Metabolic Shifts during Cardiomyocyte Differentiation, Iron Deficiency and Transferrin Rescue Using Human Pluripotent Stem Cells
por: Johnson, Benjamin B., et al.
Publicado: (2021)

Ascorbic acid can promote the generation and expansion of neuroepithelial-like stem cells derived from hiPS/ES cells under chemically defined conditions through promoting collagen synthesis
por: Bai, Rui, et al.
Publicado: (2021)

The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family
por: Jiang, Xincheng, et al.
Publicado: (2020)

Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Ranolazine: A Contemporary Review
por: Rayner‐Hartley, Erin, et al.
Publicado: (2016)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

PlnTFDB: updated content and new features of the plant transcription factor database
por: Pérez-Rodríguez, Paulino, et al.
Publicado: (2010)

Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity
por: Song, Yuanxiu, et al.
Publicado: (2022)

A Rare Neurological Complication of Ranolazine
por: Porhomayon, Jahan, et al.
Publicado: (2013)

Renal phospholipidosis possibly induced by ranolazine
por: Scheurle, Christoph, et al.
Publicado: (2014)

Improvement of Vascular Insulin Sensitivity by Ranolazine
por: Guerra-Ojeda, Sol, et al.
Publicado: (2023)

Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy
por: van Lint, Freyja H. M., et al.
Publicado: (2023)

Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008)

Emerging clinical role of ranolazine in the management of angina
por: Vadnais, David S, et al.
Publicado: (2010)

Refractory atrial fibrillation effectively treated with ranolazine
por: Vaishnav, Aditi, et al.
Publicado: (2014)

Effects of Ranolazine on Astrocytes and Neurons in Primary Culture
por: Aldasoro, Martin, et al.
Publicado: (2016)

Keratolysis exfoliativa-like eruption induced by ranolazine
por: Pierobon, Elena, et al.
Publicado: (2022)

Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?
por: Sanoudou, Despina, et al.
Publicado: (2015)

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes
por: Matsa, Elena, et al.
Publicado: (2014)

Mechanism of action of the new anti-ischemia drug ranolazine
por: Hasenfuss, G., et al.
Publicado: (2007)

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
por: Aldakkak, Mohammed, et al.
Publicado: (2013)

Anti-adrenergic effects of ranolazine in isolated rat aorta
por: Marchio, P, et al.
Publicado: (2014)

Ranolazine can markedly increase tacrolimus blood levels
por: Seck, Sidy, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m73vtao1j0fk2qkmhd042f78sd